FDA
approval
· 2024-07-26
FDA Approved: ZUNVEYL — Original Application (Alpha Cognition, Inc.)
Summary
The FDA approved ZUNVEYL (benzgalantamine) from Alpha Cognition, Inc. via an original NDA, adding a new treatment option for Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ZUNVEYL (BENZGALANTAMINE)